All lobbying filings

TODD STRATEGY GROUP

TODD STRATEGY GROUP filed a Q3 report for OTSUKA AMERICA PHARMACEUTICAL, INC. on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for OTSUKA AMERICA PHARMACEUTICAL, INC. · Pharmaceutical Manufacturer.

All filings by TODD STRATEGY GROUP · Everything OTSUKA AMERICA PHARMACEUTICAL, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Drug Pricing Policy. Issues relating to mental health as a chronic condition. Agitation in Alzheimer's.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.